B-CELL MALIGNANCIES
Clinical trials for B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough blood cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of a new drug called INCB040093, both alone and combined with another drug called itacitinib. It is for adults with B-cell blood cancers (like certain lymphomas and leukemias) that have come back or didn't respond to prio…
Matched conditions: B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cancer patients get lifeline to continue promising treatment
Disease control OngoingThis study allows people with B-cell cancers who are already taking the drug parsaclisib in another company-sponsored trial to continue receiving it. It is for patients who are benefiting from the treatment but cannot get it outside of a research study. The main goal is to monito…
Matched conditions: B-CELL MALIGNANCIES
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Cancer Drug's Long-Term safety under the microscope in major study
Disease control OngoingThis study aims to monitor the long-term safety of the cancer drug zanubrutinib in people with B-cell cancers, such as certain lymphomas and leukemias. It is open to patients who have already been taking the drug in a previous BeiGene trial and wish to continue. The main goal is …
Matched conditions: B-CELL MALIGNANCIES
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC